Iosis Capital Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 19.50 Cr
- Revenue Growth %
- Profit Growth -2931.20%
- Ebitda -4413.02%
- Net Worth -132.65%
- Total Assets 27.45%
About Iosis Capital
Iosis Capital Private Limited (ICPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 January 2020 (Five years and one month 5 days old ). Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹19.50 Cr.
Rajesh Chandrabhan and Mahesh Kingrani serve as directors at the Company.
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U65999MH2020PTC336262
- Company No.
336262
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jan 2020
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Iosis Capital?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Chandrabhan  | Director | 20-Jan-2020 | Current |
| Mahesh Kingrani | Director | 20-Jan-2020 | Current |
Financial Performance of Iosis Capital.
Iosis Capital Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 2931.2% decrease in profit. The company's net worth observed a substantial decline by a decrease of 132.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Iosis Capital?
Unlock access to Iosis Capital's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Innovative Pharmaceuticals Private LimitedRajesh Chandrabhan and Mahesh Kingrani are mutual person
Ikon Remedies Private LimitedRajesh Chandrabhan and Mahesh Kingrani are mutual person
Oak Sterling Vista LlpRajesh Chandrabhan and Mahesh Kingrani are mutual person
- Searle Remedies Limited
Rajesh Chandrabhan and Mahesh Kingrani are mutual person
- Hathway Wellness Private Limited
Rajesh Chandrabhan and Mahesh Kingrani are mutual person
- Iosis Remedies Private Limited
Rajesh Chandrabhan and Mahesh Kingrani are mutual person
Charges (Loans)
₹195.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 19.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Oct 2024 | Others | ₹19.50 Cr | Open |
How Many Employees Work at Iosis Capital?
Unlock and access historical data on people associated with Iosis Capital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Iosis Capital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iosis Capital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
